Assessment of the proarrhythmic effects of repurposed antimalarials for COVID-19 treatment using a comprehensive in vitro proarrhythmia assay (CiPA).

Saved in:

Bibliographic Details
Title:	Assessment of the proarrhythmic effects of repurposed antimalarials for COVID-19 treatment using a comprehensive in vitro proarrhythmia assay (CiPA).
Authors:	Yoon SH; R&D Center for Advanced Pharmaceuticals and Evaluation, Korea Institute of Toxicology, Daejeon, Republic of Korea.; College of Veterinary Medicine, Research Institute of Veterinary Medicine, Chungnam National University, Daejeon, Republic of Korea., Lee HL; R&D Center for Advanced Pharmaceuticals and Evaluation, Korea Institute of Toxicology, Daejeon, Republic of Korea., Jeong DU; Intelligent Human Twin Research Center, Electronics and Telecommunications Research Institute, Daejeon, Republic of Korea., Lim KM; Department of IT Convergence Engineering, Kumoh National Institute of Technology, Gumi, Republic of Korea., Park SJ; College of Veterinary Medicine, Research Institute of Veterinary Medicine, Chungnam National University, Daejeon, Republic of Korea., Kim KS; R&D Center for Advanced Pharmaceuticals and Evaluation, Korea Institute of Toxicology, Daejeon, Republic of Korea.
Source:	Frontiers in pharmacology [Front Pharmacol] 2023 Aug 15; Vol. 14, pp. 1220796. Date of Electronic Publication: 2023 Aug 15 (Print Publication: 2023).
Publication Type:	Journal Article
Journal Info:	Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1663-9812
DOI:	10.3389/fphar.2023.1220796